Publications

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.

WATSON-JONES, D; Kavunga-Membo, H; Grais, RF; Ahuka, S; Roberts, N; EDMUNDS, WJ; CHOI, EM; ROBERTS, CH; EDWARDS, T; Camacho, A; LEES, S; Leyssen, M; Spiessens, B; Luhn, K; Douoguih, M; Hatchett, R; Bausch, DG; Muyembe, J-J; DRC-EB-001 protocol writing team,;

2022

BMJ open, (2022).12 3 10.1136/bmjopen-2021-055596.

WHO-led consensus statement on vaccine delivery costing: process, methods, and findings.

Levin, A; Boonstoppel, L; Brenzel, L; Griffiths, U; Hutubessy, R; JIT, M; Mogasale, V; Pallas, S; Resch, S; Suharlim, C; Yeung, KH T;

2022

BMC MEDICINE, (2022).20 1 10.1186/s12916-022-02278-4.

Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Compariso...

Sandmann, FG; Tessier, E; Lacy, J; Kall, M; VAN LEEUWEN, E; Charlett, A; EGGO, RM; Dabrera, G; EDMUNDS, WJ; Ramsay, M; Campbell, H; Amirthalingam, G; JIT, M;

2022

Clinical infectious diseases, (2022).75 1 10.1093/cid/ciac151.

The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020.

Knight, G; Mui, T; Stimson, J; FUNK, S; Jafari, Y; Pople, D; Evans, S; Yin, M; Brown, CS; Bhattacharya, A; Hope, R; Semple, MG; Read, JM; Cooper, BS; Robotham, JV;

2022

Res Sq (2022). 10.21203/rs.3.rs-1140332/v1.

Modelling the synergistic effect of bacteriophage and antibiotics on bacteria: killers and drivers of resistance evolution.

LECLERC, Q; Lindsay, J; Knight, G;

2022

bioRxiv (2022). 10.1101/2022.03.02.480504.

Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study.

Chen, Y; Li, N; Lourenço, J; Wang, L; Cazelles, B; Dong, L; Li, B; LIU, Y; JIT, M; BOSSE, NI; ABBOTT, S; Velayudhan, R; Wilder-Smith, A; Tian, H; BRADY, OJ; CMMID COVID-19 Working Group,;

2022

The Lancet. Infectious diseases, (2022).22 5 10.1016/S1473-3099(22)00025-1.

Travel measures in the SARS-CoV-2 variant era need clear objectives.

KUCHARSKI, AJ; JIT, M; LOGAN, JG; COTTEN, M; CLIFFORD, S; QUILTY, BJ; RUSSELL, TW; PEELING, RW; ANTONIO, M; HEYMANN, DL;

2022

LANCET, (2022).399 10333 10.1016/S0140-6736(22)00366-X.

Estimating SARS-CoV-2 prevalence from large-scale wastewater surveillance: insights from combined analysis of 44 sites in England.

Morvan, M; Lojacomo, A; Souque, C; Wade, M; Hoffmann, T; Pouwels, K; Singer, A; Bunce, J; Engeli, A; Grimsley, J; O'REILLY, K; Danon, L;

2022

International Journal of Infectious Diseases, (2022).116, 10.1016/j.ijid.2021.12.057.

Mean contacts by age and date.

Gimma, A; MUNDAY, JD; WONG, KL M; Coletti, P; VAN ZANDVOORT, K; PREM, K; KLEPAC, P; Rubin, GJ; FUNK, S; EDMUNDS, WJ; JARVIS, CI;

2022

, PLOS Medicine (2022).

Planning for Compound Hazards during the COVID-19 Pandemic: The Role of Climate Information Systems.

Zaitchik, BF; Omumbo, J; LOWE, R; Van Aalst, M; Anderson, LO; Fischer, E; Norman, C; Robbins, J; Barciela, R; Trtanj, J; Von Borries, R; Luterbacher, J;

2022

Bulletin of the American Meteorological Society, (2022).103 3 10.1175/bams-d-21-0215.1.